See also this year's filing and all EDGAR filings for this company.
PDF Report 0001528172_2022_Endonovo_Therapeutics_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| warning | Excluding company: variable exceeds outlier threshold | pre-agg | {'variable': 'Liabilities', 'value': 33461585, 'size_variable': 'Assets', 'size_value': 1281266, 'ratio': 26.1, 'threshold': 20} |
Graph
Absolute values for 0001528172, Endonovo Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 94,855 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 1,912,356 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 17,701,710 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 79,825 |
| 7 | CostOfGoodsAndServicesSold | 13,605 |
| 8 | SellingGeneralAndAdministrativeExpense | 0 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 2,306,807 |
| 11 | remainder_Revenues | 73,666 |
| 12 | remainder_NetIncome | 734,442 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,007,211 |
| 1 | Liabilities | 17,781,535 |
| 2 | Expenses | 2,320,412 |
| 3 | Revenues | 73,666 |
| 4 | StockholdersEquity | -15,774,324 |
| 5 | NetIncome | -1,512,304 |
| 6 | ComprehensiveNetIncome | -1,512,304 |
| 7 | BaseVar | 11,458,633 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.63 |
| 9 | EconomicCapitalRatio | 0.492 |
Edgar->Model Mapping
Feature Distribution
Change over Time
